{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-041908","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.699748+00:00","generated_at":"2026-06-04T02:27:43.508138+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Carmell raises $3.0M in private placement of 1.33M shares at $2.25-$2.88","bullets":["Gross proceeds ~$3.0M before fees; 1,331,452 shares sold at $2.25 per share to investors and $2.88 to CEO.","CEO participation at $2.88/share equal to April 3 closing price on Nasdaq.","Proceeds for general corporate purposes; officers/directors subject to 90-day lock-up.","Registration rights agreement to be filed within 30 days of closing covering resale of shares.","Post-closing shares outstanding expected to be ~20.58 million."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-041908","json":"https://secwatch.observer/filing/0000950170-24-041908.json","markdown":"https://secwatch.observer/filing/0000950170-24-041908.md","text":"https://secwatch.observer/filing/0000950170-24-041908.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/0000950170-24-041908-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/ctcx-20240404.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:27:43.508138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74e482fe7c6e61db456a2430dfb9e288d086eb4c","claim":"Longevity Health Holdings, Inc. entered into Purchase Agreement with certain investors named therein (the \"Purchasers\") valued at approximately $3.0 million (effective 2024-04-04).","evidence_excerpt":"On April 4, 2024, Carmell Corporation, a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors named therein (the “Purchasers”) for the sale of an aggregate of 1,331,452 shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), at a price of $2.25 per share for unaffiliated investors and at a price of $2.88 per share for the Company’s Chief Executive Officer (the “Private Placement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017024041908/0000950170-24-041908-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors named therein (the \"Purchasers\")"},{"label":"Value","value":"approximately $3.0 million"},{"label":"Effective","value":"2024-04-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}